NS-PRIME Trademark

Trademark Overview


On Tuesday, May 7, 2013, a trademark application was filed for NS-PRIME with the United States Patent and Trademark Office. The USPTO has given the NS-PRIME trademark a serial number of 79132151. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 26, 2021. This trademark is owned by Alfresa Pharma Corporation. The NS-PRIME trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medical in vitro diagnostic reagents for analyzing fecal human hemoglobin; medical in vitro diagnostic reagents for analyzing fecal [ transferring ] * transferrin *; diagnostic preparations for medical purposes; diagnostic reagents for medical use; medical fecal immunochemical test reagents for human hemoglobin; medical fecal occult blood test reagents for human hemoglobin; medical fecal immunochemical test reagents for human [ transferring ] * transferrin *; medical fecal occult blood test reagents for human [ transferring ] * transferrin *

Automated immunological fecal occult blood analyzers for medical diagnostic uses; automated fecal occult blood analyzers for medical diagnostic uses; chemical clinical analyzing apparatus for medical purposes; automated discrete clinical chemistry analyzers for medical diagnostic uses; clinical medical diagnostic instruments for the analysis of body fluids; fecal immunochemical test analyzers for medical diagnostic uses
ns-prime

General Information


Serial Number79132151
Word MarkNS-PRIME
Filing DateTuesday, May 7, 2013
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 26, 2021
Registration Number4493121
Registration DateTuesday, March 11, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2013

Trademark Statements


Certificate of Correction for RegistrationAll the wording "transferring" should be deleted, and "transferrin" should be inserted in class 5.
Goods and ServicesMedical in vitro diagnostic reagents for analyzing fecal human hemoglobin; medical in vitro diagnostic reagents for analyzing fecal [ transferring ] * transferrin *; diagnostic preparations for medical purposes; diagnostic reagents for medical use; medical fecal immunochemical test reagents for human hemoglobin; medical fecal occult blood test reagents for human hemoglobin; medical fecal immunochemical test reagents for human [ transferring ] * transferrin *; medical fecal occult blood test reagents for human [ transferring ] * transferrin *
Goods and ServicesAutomated immunological fecal occult blood analyzers for medical diagnostic uses; automated fecal occult blood analyzers for medical diagnostic uses; chemical clinical analyzing apparatus for medical purposes; automated discrete clinical chemistry analyzers for medical diagnostic uses; clinical medical diagnostic instruments for the analysis of body fluids; fecal immunochemical test analyzers for medical diagnostic uses

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlfresa Pharma Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 5408575
JP

Party NameAlfresa Pharma Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 5408575
JP

Party NameAlfresa Pharma Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 5408575
JP

Trademark Events


Event DateEvent Description
Friday, May 12, 2023INTERNATIONAL REGISTRATION RENEWED
Tuesday, May 9, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 18, 2023GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, January 18, 2023INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Wednesday, January 18, 2023GENERIC MADRID TRANSACTION CREATED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, July 31, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 26, 2021CANCELLED SECTION 71
Friday, January 15, 2021NOTIFICATION PROCESSED BY IB
Friday, July 17, 2020REFUSAL PROCESSED BY IB
Monday, March 11, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, May 19, 2015INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Monday, December 15, 2014PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, July 31, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 15, 2014FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 15, 2014FINAL DISPOSITION PROCESSED
Wednesday, June 11, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, April 16, 2014CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Tuesday, April 15, 2014CORRECTION UNDER SECTION 7 ¿ PROCESSED
Tuesday, April 15, 2014ASSIGNED TO PARALEGAL
Thursday, April 3, 2014CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, March 11, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, December 24, 2013NOTIFICATION PROCESSED BY IB
Tuesday, December 24, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 4, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 4, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 13, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 8, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 8, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 6, 2013ASSIGNED TO LIE
Tuesday, November 5, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 16, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 16, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 23, 2013REFUSAL PROCESSED BY IB
Wednesday, September 4, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 4, 2013REFUSAL PROCESSED BY MPU
Saturday, August 31, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 30, 2013NON-FINAL ACTION WRITTEN
Monday, August 26, 2013ASSIGNED TO EXAMINER
Tuesday, July 16, 2013APPLICATION FILING RECEIPT MAILED
Friday, July 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 12, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 11, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB